Ireland: GreenLight Medicines Gets €500,000 to Explore Medicinal Cannabis

Warning message

The subscription service is currently unavailable. Please try again later.

As well as the funding from a group of Irish investors, Isodiol is providing €1.25m.

Pharmaceutical start-up GreenLight Medicines has secured €500,000 in funding as it seeks to develop “breakthrough medicines” using cannabis extracts.

The company, which primarily focuses on exploring the “full potential of cannabis and cannabinoids as a medicine”, secured the phase-two funding from a consortium of private Irish investors. It follows an initial €100,000 seed investment.

The new funding will enable the company to “further progress” its Irish and UK research in advancing medicines using cannabis extracts (cannabinoids) and other plant-derived molecules to treat a variety of illnesses.

In addition to the Irish investment, Swiss-American firm Isodiol has committed €1.25 million in CBD hemp oil products over a five-year period to assist GreenLight in cultivating its research studies within Irish universities.

Isodiol has also agreed a five-year research contract with GreenLight so as to further validate the...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.